First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis.
Year: 2012
Type: article
Source: PubMed
Institution: Centre Hospitalier Universitaire de Besançon
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2189179298
